Back
Marker Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
MRKR
Marker Therapeutics
Last Price:
2.94
Seasonality Move:
24.89%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Marker Therapeutics Price Quote
$2.94
-0.01 (-7.55%)
(Updated: November 22, 2024 at 4:00 AM ET)
Marker Therapeutics Key Stats
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Day range:
$2.91 - $3.20
52-week range:
$2.44 - $6.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.54%
Volume:
41.9K
Avg. volume:
46.7K
1-year change:
13.53%
Market cap:
$26.3M
Revenue:
$0
EPS:
$-1.1
How Much Does Marker Therapeutics Make?
Data Unavailable
Is Marker Therapeutics Growing As A Company?
Data Unavailable
Marker Therapeutics Stock Price Performance
-
Did Marker Therapeutics Stock Go Up Last Month?
Marker Therapeutics share price went down by -20.22% last month -
Did MRKR's Share Price Rise Over The Last Year?
MRKR share price rose by 13.53% over the past 1 year
What Is Marker Therapeutics 52-Week High & Low?
-
What Is Marker Therapeutics’s 52-Week High Share Price?
Marker Therapeutics has traded as high as $6.16 over the past 52 weeks -
What Is Marker Therapeutics’s 52-Week Low Share Price?
Marker Therapeutics has traded as low as $2.44 over the past 52 weeks
Marker Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Marker Therapeutics?
-
How Much Debt Does Marker Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Marker Therapeutics Have?
Cash and short term investments quarterly total is $9M -
What Is Marker Therapeutics’s Book Value Per Share?
Book value per share is 0.83
Is Marker Therapeutics Cash Flow Positive?
-
What Is MRKR Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.6M -
What Is Marker Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $100.5K -
What Is Marker Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Marker Therapeutics Return On Invested Capital
Data Unavailable
Marker Therapeutics Earnings Date & Stock Price
-
What Is Marker Therapeutics's Stock Price Today?
A single share of MRKR can be purchased today for 2.95 -
What Is Marker Therapeutics’s Stock Symbol?
Marker Therapeutics trades on the nasdaq under the ticker symbol: MRKR -
When Is Marker Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Marker Therapeutics is scheduled on March 25, 2025 -
When Is MRKR's next ex-dividend date?
Marker Therapeutics's next ex-dividend date is November 22, 2024 -
How To Buy Marker Therapeutics Stock?
You can buy Marker Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Marker Therapeutics Competitors
-
Who Are Marker Therapeutics's Competitors?
Below is a list of companies who compete with Marker Therapeutics or are related in some way:
Marker Therapeutics Dividend Yield
-
What Is MRKR Dividend Yield?
Marker Therapeutics’s dividend yield currently is 0% -
What Is Marker Therapeutics’s Payout Ratio?
Marker Therapeutics’s payout ratio is 0% -
When Did Marker Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Marker Therapeutics’s Dividend Per Share?
Marker Therapeutics pays a dividend of $0.00 per share
Marker Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 33.33% |
| Revenue: | 0% | 92.6% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 19.00 |
| Upside from Last Price: | 543.7% |